| Title | Phase 2 study of dasatinib in Chinese patients with chronic myeloid leukemia (CML) in chronic phase (CP) or advanced phase who are resistant to or intolerant of imatinib (IM) |
| Authors | Wang, Jianxiang Huang, Xiaojun Hu, Jianda Li, Jianyong Jin, Jie Meng, Fanyi Shen, Zhixiang Liu, Ting Wu, Depei Wang, Jianmin |
| Affiliation | Chinese Acad Med Sci, Inst Hematol, Beijing, Peoples R China. Chinese Acad Med Sci, Blood Dis Hosp, Beijing, Peoples R China. Peking Univ, Inst Hematol, Beijing, Peoples R China. Peking Univ, Peoples Hosp, Beijing, Peoples R China. Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China. Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China. Jiangsu Prov Hosp, Suzhou, Peoples R China. Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China. Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China. Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Shanghai, Peoples R China. Sichuan Univ, West China Hosp, Chengdu, Peoples R China. Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China. Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China. |
| Keywords | CML dasatinib imatinib-resistance |
| Issue Date | 2013 |
| Publisher | leukemia lymphoma |
| Citation | LEUKEMIA & LYMPHOMA.2013,54,3-+. |
| URI | http://hdl.handle.net/20.500.11897/308189 |
| ISSN | 1042-8194 |
| Indexed | SCI(E) |
| Appears in Collections: | 人民医院 |
